Interestingly, loss of one copy of Skp2 did not confer any survival advantage to recipients of heterozygous Skp2+/− ICN cells and these mice developed T-ALL with kinetics similar to recipients of Skp2+/+ ICN cells (Fig. 4a, c, S4A). Here, SKP2 is linked to acute lymphoblastic leukemia.